Docetaxel Injection USP (2019-06-03)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Docetaxel Injection USP
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| DC31711A, DC31714B | Docetaxel Injection USP | - Recalling Firm
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
- Marketing Authorization Holder
- Pfizer Canada Inc.
- 17300 Trans-Canada Hwy.
- Kirkland
- H9J 2M5
- Ontario
- CANADA
| Solution | DIN 02361957 | Docetaxel 10 mg/mL |
The impurity 10-oxo-docetaxel could be out-of-specification in the affected lots.
Healthcare establishments